GSK-109823 (HPV-019 PRI)

Study Sponsor: GSK

Study Title

Safety and immunogenicity of Cervarix™ in human immunodeficiency virus infected females

Medicine or Vaccine (generic name)

Human Papillomavirus Types 16 and 18 Vaccine

Sponsor Identification Number

109823 (HPV-019 PRI)

Trial Registry Identification Number(#'s)

NCT01031069 2013-003429-28

Medical Condition

Infections, Papillomavirus

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2020